ロード中...
Critical appraisal of elvitegravir in the treatment of HIV-1/AIDS
Human immunodeficiency virus type 1 (HIV-1) integrase inhibitors belong to a novel class of antiretroviral drugs with high potency and better tolerability. Elvitegravir (EVG) is the second integrase inhibitor approved by the US Food and Drug Administration when administered in combination with a nov...
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4037326/ https://ncbi.nlm.nih.gov/pubmed/24876793 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/HIV.S39178 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|